After five years of trial and error, Maine scallop farming startup Vertical Bay could be on the cusp of a significant breakthrough – with plans to increase production by up to fourfold next year.
Bacteriophages are poised to revolutionise aquaculture by significantly reducing mortality rates and antibiotic use, according to Dr Aristobulo Loaiza, CEO of Hedros Bio.
A new business opportunity which will involve the Centre for Aquaculture technologies (CAT) collaborating with Brazilian Fish to grow genome edited tilapia is a promising landmark – both for the companies and for the aquaculture industry as a whole.
AlgiSys BioSciences, which has developed a proprietary strain of microalgae for aquafeeds that’s rich in EPA omega-3 and alternative protein, is currently looking to raise $5 million to enable commercial-scale production.
Anthony Bellafiore, investment manager at Katapult Ocean, one of Europe’s leading aquaculture and bluetech VCs, believes that it’s too soon to write off the West's fledgling seaweed sector.
US consumers of tilapia and salmon – as well as the producers of these species in China and Canada – are likely to be the biggest losers in the seafood space if President Trump goes ahead with his planned tariff hikes.
Briana Warner, who recently surprised the seaweed world by resigning as CEO of Atlantic Sea Farms, tells The Fish Site what’s next for the company, where she’s heading next and what the future is for investments into blue foods.
Changing demographics, combined with a polarisation of global power between China and the US, makes it an interesting time for the world’s largest seafood economy.
A compound in the middle of an avocado and orange orchard, half an hour from the coast of Israel, might be an unlikely place for a marine finfish farm, but it has its advantages, according to Pure Blue Fish, a startup that’s developed a unique RAS concept.
